European Market Report for Endometrial Ablation Devices 2016 - MedCore
The endometrial ablation market has experienced consistent growth from 2012 to 2016. The modest growth can be attributed to downward pressure on ASP due to past competition in the market. Endometrial ablation procedures are expected to continue to increase, as the European market is still actively growing and has yet to reach saturation. Medical professionals are further fueling the growth of endometrial ablation procedures. In the past the surgery performed to treat menorrhagia (heavy menstrual bleeding) has favored endometrial resection over endometrial ablation. Recently, this trend has started to reverse and endometrial ablation is gaining traction in procedure numbers, eroding the number of endometrial resection procedures being performed annually.
The procedure for endometrial ablation is most commonly performed using the thermal balloon ablation or radiofrequency ablation technique. The procedure numbers can be further broken down into the technique used to perform the endometrial ablation procedure. Competitors in the market normally specialize and offer systems for a single type of endometrial ablation only. This is relevant because there is a correlation between the technique used and the market shares of different competitors.
Global endometrial ablation (GEA) is a minimally invasive surgical procedure that can remove some or all of the lining of the uterus. It is performed on women who experience abnormal or extremely heavy bleeding, also known as menorrhagia. GEA requires less training for practitioners than the earlier forms of ablation, enabling more doctors to perform the procedure and making it more accessible to patients. The first GEA products were available on the market in 1997. The other types became available mostly between 2001 and 2002. There are a number of methods by which GEA can be performed: uterine balloon, heated fluid, high-frequency radio wave, cryoablation, microwave or roller-ball.